-
Lindy Durrant appointed CEO of Scancell
firstwordpharma
July 29, 2021
Scancell Holdings plc (AIM: SCLP) is pleased to announce that Professor Lindy Durrant, founder, Board Director and Chief Scientific Officer of Scancell has been appointed Chief Executive Officer of Scancell Holdings plc with immediate effect.
-
Antengene Appoints Bo Shan as Chief Scientific Officer
prnasia
March 26, 2021
Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, announced that ...
-
Teknova appoints Neal Goodwin as CSO
expresspharma
January 15, 2021
Goodwin will expand the company’s research and development capabilities and lead market outreach for innovative products.
-
Rain Therapeutics Appoints Chief Science Officer
contractpharma
September 16, 2020
Rain Therapeutics Inc., a privately-held, clinical stage biotechnology company, has appointed Rain co-founder Robert Doebele, MD, PhD, as chief scientific officer (CSO).
-
Molecular Partners names Regeneron cancer leader as CSO in reshuffle of leadership team
fiercebiotech
June 25, 2018
Molecular Partners has rejigged its leadership team, hiring Pamela Trail, Ph.D., from Regeneron to serve as CSO and shunting Michael Stumpp, Ph.D., across to the COO position.
-
Chutes & Ladders—GlaxoSmithKline CSO Vallance out, Hal Barron in
fiercebiotech
November 13, 2017
Please send the good word—or the bad—from your shop to Angus Liu (email) and we will feature it here at the end of each week.